Skip to content

A Study on the Intervention Effect of Acupoint Massage Combined with Mindfulness Meditation on Pain and Quality of Life in Patients with Diabetic Peripheral Neuropathy

A Study on the Intervention Effect of Acupoint Massage Combined with Mindfulness Meditation on Pain and Quality of Life in Patients with Diabetic Peripheral Neuropathy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001398
Enrollment
Unknown
Registered
2025-07-12
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic peripheral neuropathy

Interventions

Joint intervention group:Acupressure + Mindfulness Meditation + Routine Treatment
Regular group:Diabetic peripheral neuropathy routine care
Acupressure regular group:Acupressure Routine treatment
Mindfulness Meditation Regular Group:Mindfulness meditation + routine care

Sponsors

Self-funded
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for diabetes formulated by the American Diabetes Association; (2) Meet the diagnostic criteria for diabetic peripheral neuropathy and be clinically diagnosed as diabetic peripheral neuropathy; (3) Meet the relevant diagnostic criteria in the Guidelines for Clinical Diagnosis and Treatment of Diabetic Peripheral Neuropathy in Traditional Chinese Medicine; (4) Pain numerical method score =2 points anxiety self-rating scale score =50 points and Pittsburgh sleep quality index scale score > 7 points; (5) Normal vision hearing language expression and comprehension skills; (6) Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Peripheral nerve pathological pain that exists at the same time or is caused by other factors; (2) Acute complications of diabetes mellitus or other serious systemic diseases or malignant tumors; (3) Local skin injury infection or allergy; (4) Those with foot ulcers or gangrene; (5) Patients with coagulation dysfunction; (6) Other patients with non-diabetic neuropathy and patients with deep vein thrombosis of the lower limbs; (7) Have cognitive dysfunction or a history of mental illness.

Design outcomes

Primary

MeasureTime frame
Numerical Rating Scale, NRS;

Secondary

MeasureTime frame
Quality of Life Scale;Sleep quality;Self Rating Anxiety Scale,SAS;

Contacts

Public ContactJuMei

teacher

2575241784@qq.com18909087186

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026